Sign in
4

Changes in Ownership

ALX ONCOLOGY HOLDINGS INC Filed Acc 0001209191-23-049102

Options or other derivatives

  • Chief Executive Officer acquired 1,200,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Lettmann Jason · Chief Executive Officer

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2023-09-08 Grant or award : show line 1 in the form Employee Stock Option (right to buy) +1,200,000 1,200,000 D
Loading xslF345X05/doc4.xml…